Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Angiotensin-converting enzyme insertion/deletion gene polymorphisms and the risk of glioma in an Algerian population.

Benenemissi IH, Sifi K, Sahli LK, Semmam O, Abadi N, Satta D.

Pan Afr Med J. 2019 Apr 23;32:197. doi: 10.11604/pamj.2019.32.197.15129. eCollection 2019.

2.

Characterization of a mixture of algae waste-bentonite used as adsorbent for the removal of Pb2+ from aqueous solution.

Kuncoro EP, Soedarti T, Putranto TWC, Darmokoesoemo H, Abadi NR, Kusuma HS.

Data Brief. 2017 Dec 16;16:908-913. doi: 10.1016/j.dib.2017.12.030. eCollection 2018 Feb.

3.

Clinical Analysis of Algerian Patients with Pompe Disease.

Sifi Y, Medjroubi M, Froissart R, Taghane N, Sifi K, Benhabiles A, Lemai S, Semra S, Benmekhebi H, Bouderda Z, Abadi N, Hamri A.

J Neurodegener Dis. 2017;2017:9427269. doi: 10.1155/2017/9427269. Epub 2017 Feb 6.

4.

γ-sarcoglycan and dystrophin mutation spectrum in an Algerian cohort.

Dalichaouche I, Sifi Y, Roudaut C, Sifi K, Hamri A, Rouabah L, Abadi N, Richard I.

Muscle Nerve. 2017 Jul;56(1):129-135. doi: 10.1002/mus.25443. Epub 2017 Feb 10.

PMID:
27759885
5.

First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.

Ziada-Bouchaar H, Sifi K, Filali T, Hammada T, Satta D, Abadi N.

Fam Cancer. 2017 Jan;16(1):57-66. doi: 10.1007/s10689-016-9917-1.

PMID:
27468915
6.

Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.

Moussaoui S, Saussoy P, Ambroise J, Defour JP, Zouitene R, Sifi K, Abadi N.

Clin Appl Thromb Hemost. 2017 Mar;23(2):105-115. doi: 10.1177/1076029615600789. Epub 2016 Jul 10.

PMID:
26304686
7.

Effects of intensity of aerobics on body composition and blood lipid profile in obese/overweight females.

Marandi SM, Abadi NG, Esfarjani F, Mojtahedi H, Ghasemi G.

Int J Prev Med. 2013 Apr;4(Suppl 1):S118-25.

8.

First study of microdeletions in the Y chromosome of Algerian infertile men with idiopathic oligo- or azoospermia.

Chellat D, Rezgoune ML, McElreavey K, Kherouatou N, Benbouhadja S, Douadi H, Cherifa B, Abadi N, Satta D.

Urol Int. 2013;90(4):455-9. doi: 10.1159/000347046. Epub 2013 Mar 16.

PMID:
23548818
9.

[Apolipoprotein E polymorphism and cerebral stroke].

Boumendjel S, Khodja D, Hamri A, Benlatreche C, Abadi N.

Ann Biol Clin (Paris). 2013 Jan-Feb;71(1):21-6. doi: 10.1684/abc.2012.0783. French.

10.

Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy.

Sifi Y, Sifi K, Boulefkhad A, Abadi N, Bouderda Z, Cheriet R, Magen M, Bonnefont JP, Munnich A, Benlatreche C, Hamri A.

J Neurodegener Dis. 2013;2013:903875. doi: 10.1155/2013/903875. Epub 2013 Mar 24.

11.

Influence of methylenetetrahydrofolate reductase C677T gene polymorphisms in Algerian infertile men with azoospermia or severe oligozoospermia.

Chellat D, Rezgoune ML, Hamane D, Semmame O, Benlatrèche C, Abadi N, Satta D.

Genet Test Mol Biomarkers. 2012 Aug;16(8):874-8. doi: 10.1089/gtmb.2011.0367.

PMID:
22928696
13.

Synergetic effects of oral administration of levamisole and Echinacea purpurea on immune response in Wistar rat.

Sadigh-Eteghad S, khayat-Nuri H, Abadi N, Ghavami S, Golabi M, Shanebandi D.

Res Vet Sci. 2011 Aug;91(1):82-5. doi: 10.1016/j.rvsc.2010.07.027. Epub 2010 Aug 24.

PMID:
20797737
14.

Intracranial cryptococcal infection in an immunocompetent patient.

Ammouri W, Harmouche H, Sefiani S, Abadi N, Adnaoui M, El Hassani A, Maaouni A.

South Med J. 2009 Nov;102(11):1187-9. doi: 10.1097/SMJ.0b013e3181bad095. No abstract available.

PMID:
19864982
15.

Fatty acid composition of HDL phospholipids and coronary artery disease.

Noori M, Darabi M, Rahimipour A, Rahbani M, Abadi NA, Darabi M, Ghatrehsamani K.

J Clin Lipidol. 2009 Feb;3(1):39-44. doi: 10.1016/j.jacl.2008.11.010. Epub 2008 Dec 9.

PMID:
21291787
16.

Effect of cyclosporin A on morphine-induced place conditioning in mice: involvement of nitric oxide.

Motiei Langroudi R, Khoshnoodi MA, Abadi NY, Tahsili Fahadan P, Ghahremani MH, Dehpour AR.

Eur J Pharmacol. 2005 Jan 10;507(1-3):107-15. Epub 2004 Dec 15.

PMID:
15659300
17.

Molecular and enzymatic characterization of a unique carnitine palmitoyltransferase 1A mutation in the Hutterite community.

Prip-Buus C, Thuillier L, Abadi N, Prasad C, Dilling L, Klasing J, Demaugre F, Greenberg CR, Haworth JC, Droin V, Kadhom N, Gobin S, Kamoun P, Girard J, Bonnefont JP.

Mol Genet Metab. 2001 May;73(1):46-54.

PMID:
11350182
18.

Genotype/phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compound heterozygous patient.

Thuillier L, Sevin C, Demaugre F, Brivet M, Rabier D, Droin V, Aupetit J, Abadi N, Kamoun P, Saudubray JM, Bonnefont JP.

Neuromuscul Disord. 2000 Mar;10(3):200-5.

PMID:
10734268
19.

Carnitine palmitoyltransferase deficiencies.

Bonnefont JP, Demaugre F, Prip-Buus C, Saudubray JM, Brivet M, Abadi N, Thuillier L.

Mol Genet Metab. 1999 Dec;68(4):424-40. Review.

PMID:
10607472
20.

High-resolution solution structure of the EGF-like domain of heregulin-alpha.

Jacobsen NE, Abadi N, Sliwkowski MX, Reilly D, Skelton NJ, Fairbrother WJ.

Biochemistry. 1996 Mar 19;35(11):3402-17.

PMID:
8639490
21.

Identification of heregulin, a specific activator of p185erbB2.

Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, et al.

Science. 1992 May 22;256(5060):1205-10.

PMID:
1350381

Supplemental Content

Support Center